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Development of SCN Connectivity and the Circadian
Control of Arousal: A Diminishing Role for Humoral
Factors?
Andrew J. Gall¤, William D. Todd, Mark S. Blumberg*
Department of Psychology, University of Iowa, Iowa City, Iowa, United States of America

Abstract
The suprachiasmatic nucleus (SCN) is part of a wake-promoting circuit comprising the dorsomedial hypothalamus (DMH)
and locus coeruleus (LC). Although widely considered a ‘‘master clock,’’ the SCN of adult rats is also sensitive to feedback
regarding an animal’s behavioral state. Interestingly, in rats at postnatal day (P)2, repeated arousing stimulation does not
increase neural activation in the SCN, despite doing so in the LC and DMH. Here we show that, by P8, the SCN is activated by
arousing stimulation and that selective destruction of LC terminals with DSP-4 blocks this activational effect. We next show
that bidirectional projections among the SCN, DMH, and LC are nearly absent at P2 but present at P8. Despite the relative
lack of SCN connectivity with downstream structures at P2, day-night differences in sleep-wake activity are observed,
suggesting that the SCN modulates behavior at this age via humoral factors. To test this hypothesis, we lesioned the SCN at
P1 and recorded sleep-wake behavior at P2: Day-night differences in sleep and wake were eliminated. We next performed
precollicular transections at P2 and P8 that isolate the SCN and DMH from the brainstem and found that day-night
differences in sleep-wake behavior were retained at P2 but eliminated at P8. Finally, the SCN or DMH was lesioned at P8:
When recorded at P21, rats with either lesion exhibited similarly fragmented wake bouts and no evidence of circadian
modulation of wakefulness. These results suggest an age-related decline in the SCN’s humoral influence on sleep-wake
behavior that coincides with the emergence of bidirectional connectivity among the SCN, DMH, and LC.
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during sleep and wakefulness [8], thereby indicating feedback
control of the SCN. The anatomical pathways through which the
SCN receives feedback about vigilance state are not known. One
possibility, tested here, is that this feedback is mediated in part by
the LC and DMH.
If the LC and DMH do modulate SCN activity, a recent study
suggests that they do so only after P2, at least with regard to
arousing stimulation. Todd et al. [9] enforced arousal in an infant
rat by applying a chilled metal spatula to a region of the snout that
contains a high density of cold thermoreceptors [10]. The effect of
30 min of arousing stimulation on neural activity was assessed
using Fos immunoreactivity (Fos-ir). Although the LC and DMH
were significantly activated by this procedure, the SCN was not. In
light of the Deboer et al. [8] findings of state-dependent
modulation of SCN activity in adults, as well as evidence that
electrical stimulation of the LC in adults directly or indirectly
activates the SCN [11], we hypothesized that arousing stimulation
would evoke SCN activity sometime after P2.
To test this hypothesis, we repeated the Todd et al. [9]
experiment at P8. We found that the SCN, in addition to the
DMH and LC, is significantly activated by 30 min of arousing
stimulation and that this SCN activation requires a functionally
intact LC. Next, we found that bidirectional neural projections

Introduction
The suprachiasmatic nucleus (SCN), a hypothalamic structure
critical for the circadian control of arousal, modulates the activity
of many downstream structures, including the dorsomedial
hypothalamus (DMH) and locus coeruleus (LC) [1]. Although
SCN rhythms of metabolic activity are first detectible prenatally at
embryonic day (E)19 [2], little is known about the contributions of
the SCN and its downstream targets to infant behavior. It is
known, however, that day-night differences in sleep and wakefulness are expressed as early as postnatal day (P)2 and that nocturnal
wakefulness emerges by P15 [3]. Also by P15, wake bouts, but not
sleep bouts, transition from an exponential distribution (for which
the probability of a state transition is constant at all bout lengths)
to a power-law distribution (which is characterized in part by
a small proportion of very long bouts) [3,4]. Therefore, here we
investigate the developmental relations between the SCN-DMHLC circuit and sleep-wake behavior across the first 3 postnatal
weeks, a period of rapid and pronounced changes in sleep-wake
organization [5].
The SCN is widely considered a ‘‘master clock’’ that broadcasts
circadian signals to the brain and periphery [6,7]. However, the
SCN’s spontaneous neural activity is also differentially modulated
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during the middle of the light period at 1300 h. Each recording
consisted of 2 consecutive 30-min periods: a baseline period and
a stimulation period. During the baseline period, all pups were
allowed to cycle between sleep and wakefulness while EMG data
were recorded. During the stimulation period, a cold, metal
spatula was applied to the snout [9]. The stimulus was only applied
when the subject was asleep, as indicated by nuchal atonia
accompanied by behavioral quiescence or myoclonic twitching.
Between stimulus presentations, spatulas were kept in a beaker
containing ice water. Each stimulus application was recorded in
synchrony with EMG data acquisition. Same-sex littermate
controls were prepared identically except they were allowed to
cycle undisturbed between sleep and wakefulness throughout the 2
30-min periods. As described in our previous study [9], infant
animals cycle so quickly between states of sleep and wakefulness
that it is not possible to employ a yoked control procedure.
After the stimulation period, pups were left undisturbed in the
chamber for 90 min. They were then removed from the chamber,
killed with an overdose of Nembutal, and perfused transcardially
with phosphate buffered saline (PBS) followed by 4% paraformaldehyde (PFA). Brains were removed and post-fixed overnight in 4% PFA before being transferred to 30% sucrose solution.
Fos immunoreactivity. Coronal sections (40 mm) were cut
using a microtome (Model SM 2000 R, Leica, Bensheim,
Germany) and placed in wells filled with PBS. Sections were then
placed in normal goat serum for 1 h, rinsed again with PBS, and
incubated in a primary antibody solution (1:2000, sc-7202, in
.01 M PBS and 0.3% Triton X; Santa Cruz Biotechnology, Santa
Cruz, CA). After 24 h, sections were rinsed with PBS and
incubated in biotinylated goat anti-rabbit IgG secondary antibody
(1:200; Vector Laboratories, Burlingame, CA) for 1 h in .01 M
PBS and .3% Triton X. Sections were rinsed with PBS and placed
in an avidin-biotin peroxidase complex (Vector Laboratories) for
1 h. The sections were again rinsed with PBS before being placed
in a diaminobenzidine solution with hydrogen peroxide (Sigma,
St. Louis, MO). The sections were placed in PBS to stop the
reaction. Sections were mounted and coverslipped.
Data Analysis. The number of stimulus presentations was
quantified for all 6 5-min segments during the 30-min stimulation
period. A microscope (Leica Instruments, Wetzlar, Germany) and
imaging system were used to visualize 40 mm brain sections using
a 20x objective. Images were imported into ImageJ (National
Institutes of Health) and adjusted to binary values.
Using methods similar to those used previously [9], for each
subject Fos-positive cells were counted unilaterally in 2–3 sections
using a counting box of known dimensions. The experimenter was
blind to experimental group. An Abercrombie correction was
performed for each area within each section [16]. The mean
number of Fos-positive cells per brain area was then calculated for
each pup.
In addition to the LC, DMH, and SCN, other areas were
selected for quantification. The barrel cortex was selected because
it receives somatosensory inputs from the whisker pad [17];
therefore, this area was used as a positive control to demonstrate
the sensitivity of the Fos-ir method for detecting somatosensory
stimulation of the snout. The following additional wake-related
brain areas and nuclei [18–23] were selected for quantification:
laterodorsal tegmental nucleus (LDT), lateral hypothalamus (LH),
basal forebrain (BF), ventral tegmental nucleus (VTg), dorsal
tegmental nucleus (DTg), medial preoptic area (MPOA), perifornical area (PeF), and tuberomammillary nucleus (TMN). The
following sleep-related brain areas and nuclei [20,24,25] were also
selected: nucleus pontis oralis (PO), median preoptic nucleus
(MnPO), ventrolateral preoptic nucleus (VLPO), dorsal raphe

among the SCN, DMH, and LC emerge between P2 and P8.
Finally, we used lesions and transections to assess the contributions
of the SCN and DMH to the consolidation and circadian
rhythmicity of sleep and wake bouts before and after the
emergence of bidirectional connectivity. Our findings suggest
a model of SCN function that includes humoral influences on
behavioral state early in development and a predominating
influence of direct neural connections by the end of the first
postnatal week.

Materials and Methods
All experiments were carried out in accordance with the
National Institutes of Health Guide for the Care and Use of
Laboratory Animals (NIH Publication No. 80–23) and were
approved by the Institutional Animal Care and Use Committee of
the University of Iowa.

Subjects
A total of 197 Sprague-Dawley Norway rats (Rattus norvegicus)
from 109 litters were used in this study. All efforts were made to
minimize the number of animals used. For all experiments, males
and females were equally represented and littermates were always
assigned to different experimental groups. Litters were culled to 8
pups within 3 days of birth (day of birth = P0). Mothers and their
litters were housed and raised in standard laboratory cages
(48620626 cm) in the animal colony at the University of Iowa.
Food and water were available ad libitum. All animals were
maintained on a 12-h light-dark schedule with lights on at 0700 h.

Arousing stimulation and Fos immunoreactivity at P8
Subjects. Twenty-four infant rats from 6 litters (n = 6 per
group x4 groups) were used. Littermates were assigned to different
experimental groups. At P3 (body weights: 7.2–10.1 g), 2 same-sex
pups with visible milk bands were removed from the litter and
injected with N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine
(DSP-4; 50 mg/kg); the other 2 same-sex pups were injected with
saline. DSP-4 is a neurotoxin that selectively destroys noradrenergic LC terminals in infant and adult rats [12–14]. Pups were
placed back in the litter until recording at P8 (body weights: 16.7–
20.1 g; there were no significant group differences in body weight).
Apparatus. The recording chamber consisted of an electrically shielded double-walled glass chamber (height = 17 cm, i.d.
= 12.5 cm) sealed with a lid. An access hole in the side of the
chamber allowed for the passage of electromyographic (EMG)
electrodes. Heated water circulated through the walls of the glass
chamber to maintain air temperature at thermoneutrality (i.e.,
35uC).
Procedure. On the day of recording and under isoflurane
anesthesia, 4 littermates were implanted with EMG electrodes in
the nuchal muscle. As described previously [15], two bipolar
stainless steel electrodes (50 mm diameter, California Fine Wire,
Grover Beach, CA) were inserted bilaterally into the nuchal
muscles and secured with flexible collodion, Each pup was
assigned to one of four experimental groups: Stimulated/Saline,
Non-stimulated/Saline, Stimulated/DSP-4, and Non-stimulated/
DSP-4. Each pup was lightly restrained in a supine position,
transferred to the recording chamber, and allowed 1 h to recover
and acclimate.
EMG electrodes were connected to differential amplifiers (A–M
systems, Carlsborg, WA) and their signals were amplified (x10 k)
and filtered (300–5000 Hz). EMG data were acquired (1000
samples/s) and stored using a data acquisition system (BioPac
Systems, Santa Barbara, CA). EMG recordings always occurred
PLOS ONE | www.plosone.org
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Figure 1. The effect of arousing stimulation at P8 on the SCN-DMH-LC wake-promoting circuit. (A) Mean number of Fos-positive cells per
section in the LC, DMH, and SCN in P8 rats of Stimulated/Saline (n = 6), Non-Stimulated/Saline (n = 6), Stimulated/DSP-4 (n = 6), and Non-Stimulated/
DSP-4 (n = 6) pups. * Significant difference from all other groups. Means + SE. (B) Photographs of the LC, DMH, and SCN in Stimulated/Saline (first
row), Non-Stimulated/Saline (second row), Stimulated/DSP-4 (third row), and Non-Stimulated/DSP-4 (fourth row) pups at P8. The inset represents
a 100X magnification of cFos+ neurons within the SCN (white square). Abbreviations: LC: locus coeruleus; DMH: dorsomedial hypothalamus; SCN:
suprachiasmatic nucleus.
doi:10.1371/journal.pone.0045338.g001

(DR), and median raphe (MR). Finally, the ventral subparaventricular zone (vSPVZ), which is connected to the SCN and DMH
[19] and is important for circadian rhythms of sleep and

PLOS ONE | www.plosone.org

wakefulness [26], was also selected, as was the paraventricular
nucleus (PVN), a hypothalamic nucleus important for stress
responses [27].
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Table 1. Mean (SE) number of Fos-positive cells per section for the four experimental groups tested at P8.

Stimulated/Saline

Non-Stimulated/Saline

Stimulated/DSP-4

Non-Stimulated/DSP-4

MPOA

14.6 (1.5)

7.9 (1.3)

8.7 (2.6)

8.0 (1.0)

PeF

17.3 (2.2)

8.7 (1.9)

9.5 (1.1)

9.7 (1.0)

TMN

15.0 (1.3)

8.3 (0.5)

8.0 (1.0)

5.2 (0.6)

Barrel Cortex

28.5 (5.8)

8.2 (1.5)

19.1 (3.4)

6.8 (1.4)

BF

27.1 (4.2)

13.6 (2.0)

23.0 (4.9)

12.1 (2.0)

LDT

24.5 (2.8)

9.2 (1.0)

20.8 (2.7)

8.7 (1.0)

VLPO

6.9 (0.6)

6.9 (0.5)

4.8 (0.4)

6.6 (1.4)

vSPVZ

13.2 (1.3)

9.7 (1.2)

9.4 (0.7)

9.8 (1.2)

MnPO

18.2 (4.0)

13.1 (2.3)

12.2 (2.2)

10.7 (2.5)

LH

14.6 (1.8)

9.3 (1.9)

12.8 (1.6)

10.0 (2.2)

PVN

40.7 (4.7)

37.1 (6.4)

36.8 (5.1)

42.8 (4.5)

DR

13.0 (2.0)

9.8 (2.8)

8.6 (1.7)

7.8 (0.6)

MR

19.7 (3.0)

14.3 (1.8)

14.7 (2.3)

12.4 (1.6)

DTg

24.6 (3.3)

31.0 (2.1)

23.5 (3.2)

27.8 (2.5)

VTg

24.1 (3.4)

15.9 (3.2)

20.7 (2.7)

17.0 (2.5)

PO

11.1 (2.5)

10.3 (1.6)

10.2 (1.1)

10.8 (1.2)

Data for SCN, DMH, and LC are presented in Figure 1.
Bolded values significantly different from unbolded values within each brain area.
Abbreviations: LC: locus coeruleus, DMH: dorsomedial hypothalamus, SCN: suprachiasmatic nucleus, LDT: laterodorsal tegmental nucleus, BF: basal forebrain, PeF:
perifornical nucleus, TMN: tuberomammillary nucleus, VTg: ventral tegmental nucleus, MPOA: medial preoptic area, vSPVZ: ventral subparaventricular zone, LH: lateral
hypothalamus, VLPO: ventrolateral preoptic nucleus, MnPO: median preoptic nucleus, PO: pontis oralis, DR: dorsal raphe, MR: median raphe, DTg: dorsal tegmental
nucleus.
doi:10.1371/journal.pone.0045338.t001

A two-way analysis of variance (ANOVA) was used to analyze
group differences for each area sampled. Fisher’s PLSD was used
as a post hoc test. Alpha was set conservatively at .01 to
compensate for multiple comparisons.

DiI and CTB tracing
DiI crystal in fixed tissue. Four P2 (body weights: 6.9–
9.2 g) and 4 P8 (body weights: 17.1–19.9 g) rats from 8 litters were
used. Pups were removed from the litter during the middle of the
lights-on period (1430 h), killed, and perfused as described above.
Brains were extracted and allowed to soak in 4% PFA for at least
24 h. Each brain was then removed from the PFA solution and
placed on its dorsal surface under a dissecting microscope. Using
forceps, a FAST DiI crystal (Molecular Probes, Eugene, OR) was
carefully inserted unilaterally within the SCN, which is immediately dorsal to the optic chiasm. Placement of the crystal was
counterbalanced such that 4 subjects had a crystal placed into the
left side of the SCN, and 4 subjects had a crystal placed into the
right side of the SCN. Each brain was then placed back in the PFA
solution and allowed to soak for 6 weeks in a dark glass jar at 4uC
[28], after which remaining crystal was removed with a forceps.
Using a freezing microtome, brains were sliced in 40 mm sections
and coverslipped using Vectastain hard set (Vector Laboratories,
Burlingame, CA). Every other slice was used for fluorescence
analysis. Remaining sections were stained with cresyl violet.
CTB in vivo. Four P2 (body weights: 7.0–8.8 g) and 4 P8
(body weights: 16.0–20.4 g) rats from 8 litters were used. Under
isoflurane anesthesia, pups were secured in a stereotaxic instrument. A small hole was drilled at the following coordinates:
AP: 22.2 mm caudal to bregma, ML: 0.2 mm from midline, DV:
26.0 mm from the surface of the brain. Placement of the syringe
was counterbalanced between the left and right DMH. A 30 gauge
needle attached to a 1 ml Hamilton syringe was filled with Alexa

Figure 2. Neural tracing with DiI at P2 and P8 in the SCN. One
DiI crystal was placed in the SCN of fixed tissue at P2 (left) and P8
(right). Top row depicts placement of crystal. Bottom row depicts
fluorescence in DMH, LH, and VMH. The inset is a magnified view to
reveal cell bodies and axon terminals in the DMH. n = 4 subjects per
group. Abbreviations: DMH: dorsomedial hypothalamus; LH: lateral
hypothalamus; VMH: ventromedial hypothalamus; vSPVZ: ventral
subparaventricular zone; SCN: suprachiasmatic nucleus.
doi:10.1371/journal.pone.0045338.g002

PLOS ONE | www.plosone.org

4

September 2012 | Volume 7 | Issue 9 | e45338

Development of SCN Activity and Arousal

system (Leica Instruments, Wetzlar, Germany). Fluorescent
sections were directly compared to adjacent counterstained Nissl
sections. Images of fluorescent and Nissl sections were overlayed
using Adobe Photoshop to determine the location of DiI or CTB
labeling.
For each subject, fluorescence was quantified unilaterally in 1–4
sections per brain area. Fluorescent images were imported into
ImageJ (National Institutes of Health) and the mean red intensity
was analyzed using the RGB Measure plugin. For subjects in
which a DiI crystal was implanted in the SCN, mean fluorescence
intensity was analyzed within the DMH and LC. For subjects in
which CTB was injected into the DMH, mean fluorescence
intensity was analyzed within the SCN and LC. The experimenter
was blind to experimental group and age. Unpaired t tests were
used to analyze age group differences (i.e., P2 vs. P8) in mean
fluorescence intensity. Alpha was set at .05.

SCN lesions at P1
Procedure. Twenty rats from 10 litters (n = 5 per group with
2 recording times x 2 conditions) were used. Littermates were
assigned to different experimental groups. On P1 (body weights:
5.9–8.4 g), a subject with a visible milk band was removed from
the litter and, beginning at 1000 h, anesthetized with isoflurane
and secured in a stereotaxic apparatus (David Kopf Instruments,
Tujunga, CA, USA). Using an insulated tungsten concentric
bipolar electrode (1 MV, 3–4 mm at the tip, Model TM33CCINS,
World Precision Instruments, Sarasota, FL, USA), bilateral
electrolytic lesions were made in the SCN. Electrolytic lesions
were necessary because SCN neurons are resistant to excitotoxicity
29]. The following coordinates were used: AP: 20.2 mm from
bregma, ML: 6S0.1 mm, and DV: 24.5 mm ventral to the
meningeal surface. Lesions were made using a stimulus generator
(Model SD9F, Grass Technologies, Quincy, MA, USA) and
a linear stimulus isolator (Model A395R, World Precision
Instruments, Sarasota, FL, USA) to deliver 1.0 mA of DC current
for 30 s. Vetbond was used to close the incision and peanut oil was
brushed lightly on the scalp. The sham control group experienced
the same procedure except that current was not applied. EMG
electrodes were implanted as described above.
After surgery, pups recovered for at least 2 h inside a humidified
incubator maintained at 34–35uC. Subjects were then placed back
in the litter. On the next day at P2 (body weights: 6.8–9.4 g; there
were no significant group differences in body weight), subjects
were recorded during the day (1200–1400 h) or night (2400–
0200 h), with order of recording time counterbalanced. Pups were
recorded for sleep and wakefulness using methods identical to
those described above. At the conclusion of recording, pups were
overdosed with sodium pentobarbital and perfused transcardially,
as described above.
Histology. Brains were sliced in 50 mm sections using
a freezing microtome. Brain slices were stained with cresyl violet.
The extent of the lesion was determined by examining sequential
brain slices.
Data Analysis. EMG data were analyzed using AcqKnowledge software (BioPac Systems, Santa Barbara, CA). EMG signals
were integrated and full-wave rectified, and dichotomized into
high muscle tone and atonia (or wake and sleep, respectively), as
described previously [30]. Data were scored by an individual blind
to experimental condition. Sleep and wake bout durations were
imported into Statview 5.0 (SAS Institute, Cary, NC) for analysis.
Mean sleep and wake bout durations were determined for each
subject [3,31]. Percentage of time awake was calculated by
dividing the mean wake bout duration by the sum of the mean
sleep and wake bout durations, and then multiplying by 100.

Figure 3. Neural tracing with CTB at P2 and P8 in the DMH.
Fluorescent CTB was injected unilaterally (0.1 mL) into the DMH at P2
(left) and P8 (right). Top row depicts the injection site of CTB. Bottom 2
rows depict fluorescence in vSPVZ, SCN, LC, and MeV. The insets are
magnified views to reveal cell bodies and axon terminals in the SCN
(middle row) and LC (bottom row). n = 4 subjects per group.
Abbreviations are identical with those of Figure 2, but with the
addition of Mesencephalic of V (MeV) and locus coeruleus (LC).
doi:10.1371/journal.pone.0045338.g003

Fluor 594 (Texas-Red)-conjugated Cholera Toxin B Subunit
(CTB) (1 mg/ml; Molecular Probes, Eugene, OR, USA). Once the
target area was reached, the needle was left in place for 1 min,
after which 0.1 ml of CTB was infused over 30 s. After the
injection, the needle remained in the brain for 1 min and then
removed slowly. Vetbond was used to close the incision and
peanut oil was brushed lightly on the scalp to deter the mother
from reopening the wound. The pup recovered for at least 2 h in
a humidified incubator maintained at thermoneutrality and then
placed back in the litter. Three days later, pups were removed
from the litter during the middle of the lights-on period (1430 h),
killed, and perfused as described above.
Data Analysis. Sections were analyzed for the presence or
absence of DiI or CTB labeling (i.e., fluorescent cell bodies and/or
axon terminals) using a fluorescent microscope and imaging
PLOS ONE | www.plosone.org
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Figure 4. Effects of SCN lesions at P2 on sleep and wakefulness during the day and night. (A) Log-survivor plots of pooled sleep (left
column) and pooled wake (right column) bout durations for subjects that experienced sham surgery or SCN lesions at P1 and recorded at P2 (1169–
1932 points per plot). Pups were recorded during the day (red) and at night (blue) in shams (solid line) and SCN lesioned pups (dashed line). Insets
provide mean sleep and wake bout durations for sham and lesioned pups during the day and at night. *Significantly different. n = 5 subjects per
group. Means + SE. (B) Photograph of a representative bilateral electrolytic SCN lesion performed at P1 with recording occurring at P2 (left) followed
by 3 sequential images (rostral to caudal) depicting the smallest (green filled area) and largest (yellow filled area) lesions per coronal section across all
lesioned subjects. Sections are 500 mm apart. Abbreviations: SCN: suprachiasmatic nucleus; 3V: third ventricle; MPOA: medial preoptic area; LPO:
lateral preoptic area; VLPO: ventrolateral preoptic area; ox: optic chiasm; PaAP: Anterior part of parvicellular nucleus; AHA: anterior hypothalamic area,
anterior; AHC: anterior hypothalamic area, central.
doi:10.1371/journal.pone.0045338.g004

were used to test for day-night differences within groups. Alpha
was set at 0.05 and Bonferroni corrections were used when
appropriate. Means are presented with standard errors.

As described previously [4], log-survivor distributions of sleep
and wake bout durations were produced from individual and
pooled data. To test whether pooled bout duration data were
better fit by a power-law or exponential model, log-likelihood
functions were calculated and maximized for each model [32–34].
The comparison was quantified by calculating Akaike weights, wi
(i = 1,2), for each model: wi = exp(2Di/2)/(exp(2D1/2) +
exp(2D2/2)). Di is a measure of each model relative to the better
model; Di = 0 for the model with larger log-likelihood value. For
the other model, Di .0 is calculated as the difference of Akaike
Information Criterion (AIC) values, AICi = 22(log-likelihoodi)
+2ki, where ki is the number of parameters in model i. The Akaike
weight for a model estimates the probability that the model is the
better of the two candidate models [32,35]. A model with a weight
of 1 is a better fit than a model with a weight of 0.
A two-way ANOVA was used to test for differences across
groups (i.e., lesion vs. control) and recording times (i.e., day vs.
night). If an interaction was significant, post hoc tests using Fisher’s
PLSD were performed. Planned comparisons (i.e., unpaired t tests)
PLOS ONE | www.plosone.org

Precollicular transections at P2 and P8
Procedure. Twenty-four P2 rats (body weights: 6.9–9.2 g)
from 6 litters (n = 6 per group with 2 recording times x 2
conditions) and 24 P8 rats (body weights: 16.8–21.2 g) from 6
litters (n = 6 per group with 2 recording times x 2 conditions) were
used. Littermates were assigned to different experimental groups.
On the day of recording, a pup with a visible milk band was
removed from the litter. Under isoflurane anesthesia, precollicular
transections were made by drilling a small hole in the skull
approximately 3 mm caudal to lambda, and then manually
inserting a blunted 25 g needle to the base of the brain and
rotating the needle using a side-to-side motion [30,31]. Sham
littermates of the same age underwent anesthesia and drilling, but
the needle was not inserted. Vetbond was used to close the incision
and peanut oil was brushed lightly on the scalp. Next, two bipolar
6
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Figure 5. Effects of precollicular transections on day-night differences in sleep and wakefulness. Log-survivor plots of pooled sleep (left
column) and pooled wake (right column) bout durations for (A) P2 and (B) P8 subjects that experienced sham surgery or precollicular transections
(996–1732 points per plot for P2; 657–1215 points per plot for P8). Sham (solid lines) and transected (dashed lines) pups were recorded during the
day (red lines) and night (blue lines). Insets present mean sleep and wake bout durations for sham and lesioned pups during the day and at night. *
Significantly different from corresponding daytime value. n = 6 subjects per group. Means + SE. The ranges of transections in the sagittal plane are
presented at the far right. Abbreviations: AC: anterior commissure; SCN: suprachiasmatic nucleus; Th: thalamus; SC: superior colliculus.
doi:10.1371/journal.pone.0045338.g005

stainless steel electrodes (50 mm diameter, California Fine Wire,
Grover Beach, CA) were inserted bilaterally into the nuchal
muscles and secured with flexible collodion [15]. After surgery,
pups recovered in a humidified incubator maintained at thermoneutrality (34–35uC) for at least 1 h before recording.
Subjects were recorded in pairs in 2 identical electrically
shielded double-walled glass chambers during the day (1200–
1400 h) and at night (2400–0200 h), with order of recording time
counterbalanced. Air temperature in the chambers was regulated
at thermoneutrality (i.e., 35.5uC). Nuchal electrodes were connected to differential amplifiers (A–M systems, Carlsborg, WA)
and their signals were amplified (x10k) and filtered (300–5000 Hz).

PLOS ONE | www.plosone.org

EMG data were acquired (1000 Hz) and stored using a data
acquisition system (BioPac Systems, Santa Barbara, CA).
Immediately after recording, all subjects were overdosed with
sodium pentobarbital and perfused transcardially with PBS
followed by 3% formalin. Heads were post-fixed in a sucroseformalin solution for at least 24 h.
Histology. The rostrocaudal placement of the transection
was determined using gross visual inspection of each brain and
drawn onto a photomicrograph of a P2 or P8 sagittal section.
Data Analysis. Data analysis was similar to that described
above for the SCN lesions at P2.
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Figure 6. Effects of DMH lesions at P21 on sleep and wakefulness during the day and night. (A) Log-survivor plots of pooled sleep (left
column) and pooled wake (right column) bout durations for subjects that experienced sham surgery or DMH lesions at P8 and recorded at P21 (658–
921 points per plot). Pups were recorded during the day (red) and at night (blue) in shams (solid line) and DMH lesioned pups (dashed line). Insets
provide mean sleep bout durations for sham and lesioned pups during the day and at night. * Significantly different. n = 6 subjects per group. Means
+ SE. (B) Photograph of a representative bilateral ibotenic acid lesion performed at P8 with recording occurring at P21 (left) followed by 3 sequential
images (rostral to caudal) depicting the smallest (green filled area) and largest (yellow filled area) lesions per coronal section across all lesioned
subjects. Sections are 500 mm apart. Abbreviations: DMH: dorsomedial hypothalamus; 3V: third ventricle; LH: lateral hypothalamus; AHP: anterior
hypothalamic area, posterior; VMH: ventromedial hypothalamus; Arc: arcuate nucleus; PeF: perifornical nucleus; PH: posterior hypothalamus; f: fornix.
doi:10.1371/journal.pone.0045338.g006

After lesions were produced, Vetbond was used to close the
incision and peanut oil was brushed lightly on the scalp. Pups were
placed in an incubator for at least 2 h to recover, and then placed
back in the litter. On the day of recording at P21 (body weights:
52.4–69.7 g; there were no significant group differences in body
weight), one lesioned pup and one control pup was placed in
separate humidified chambers maintained at thermoneutrality for
pups at this age (i.e., 29uC). Littermate pairs were recorded for 6 h
either during the day (1000–1600 h) or at night (2200–0400 h),
with order of recording time counterbalanced across pairs. After
recording, pups were killed and perfused as described above.
Brains were postfixed and sliced to observe the extent of the
lesions, as described above.
Data Analysis. Data analysis was similar to that described
above for the SCN lesions at P2.
Unless otherwise noted, all means are presented with their
standard errors.

SCN and DMH lesions at P8
Forty-eight rats from 24 litters (n = 6 per group
with 2 recording times x 4 conditions) were used. Littermates were
assigned to different experimental groups. At P8 (body weights:
17.4–20.5 g), a subject with a visible milk band was removed from
the litter. Under isoflurane anesthesia and using a stereotaxic
apparatus, bilateral lesions were produced either in the SCN or
DMH.
For SCN lesions, the following electrode coordinates were used:
AP: 20.2 mm from bregma, ML: 60.1 mm, and DV: 25.5 mm
ventral to the meningeal surface. A littermate control experienced
the same procedures except that current was not applied. For
DMH lesions, 0.1 ml of a 10% ibotenic solution (Sigma, St. Louis,
MO) was injected bilaterally using the following coordinates AP:
22.2 mm caudal to bregma, ML: 60.2 mm from midline, DV:
26.0 mm from the surface of the brain. The rate of infusion was
0.1 ml / 30 s. A littermate control experienced the same procedure
except 0.1 ml of saline was injected bilaterally.
Procedure.
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Figure 7. Effects of SCN lesions at P21 on sleep and wakefulness during the day and night. (A) Log-survivor plots of pooled sleep (left
column) and pooled wake (right column) bout durations for subjects that experienced sham surgery or SCN lesions at P8 and recorded at P21 (658–
937 points per plot). Pups were recorded during the day (red) and at night (blue) in shams (solid line) and SCN lesioned pups (dashed line). Insets
provide mean sleep bout durations for sham and lesioned pups during the day and at night. *Significantly different from the corresponding daytime
value. n = 6 subjects per group. Means + SE. (B) Photograph of a representative bilateral electrolytic SCN lesion performed at P8 with recording
occurring at P21 (left) followed by 3 sequential images (rostral to caudal) depicting the smallest (green filled area) and largest (yellow filled area)
lesions per coronal section across all lesioned subjects. Sections are 500 mm apart. Abbreviations are identical to Figure 4.
doi:10.1371/journal.pone.0045338.g007

groups; this pattern reflects sensory processing that is dependent
on the LC. Second, there were areas (e.g., barrel cortex) exhibiting
significantly higher Fos-ir in the stimulated groups compared with
the non-stimulated groups; this pattern reflects sensory processing
that is not dependent on the LC. Third, there were areas (e.g.,
DTg, MnPO, VLPO) that were not affected by any of the
manipulations.
It is possible that stress associated with the stimulation
procedure contributed to the increased Fos-ir in the SCN,
DMH, and LC. We tested this possibility by measuring Fos-ir in
the PVN, an important central component of the stress response
[27]. We found no evidence of increased Fos-ir in the PVN in the
Stimulated/Saline or Stimulated/DSP-4 groups in relation to the
Non-Stimulated groups (see Table 1).
Similar to previous results [9], P8 saline-treated subjects
required significantly more stimulus presentations over the last 5
min of the stimulation period (46.364.6 stimulations) as compared
to the first 5 min of the stimulation period (17.862.4 stimulations)
to keep them awake (t10 = 9.8, P,.001), a sign of increased sleep
pressure. This was not the case, however, for DSP-4-treated pups
(22.563.5 stimulations in first 5 min as compared to 23.563.9

Results
At P8, DSP-4 blocks the activating effects of arousing
stimulation on the SCN
As reported previously, arousing stimulation in P2 rats resulted
in increased Fos-ir in the LC and DMH, but not the SCN [9].
Here, at P8, Stimulated/Saline pups expressed significantly more
Fos-ir in the LC and DMH, and also in the SCN, as compared
with all other conditions (Figure 1A). For the LC, DMH, and
SCN, ANOVAs revealed significant main effects of group (i.e.,
saline vs. DSP-4; F1,20s .6.8, Ps,.05) and condition (i.e.,
stimulated vs. non-stimulated; F1,20s .4.4, Ps,.05), and significant group x condition interactions (F1,20s .8.3, Ps,.01).
Therefore, DSP-4 was effective in blocking sensory-related
activation of the SCN. Figure 1B depicts representative images
of the LC, DMH, and SCN in the 4 experimental conditions.
Table 1 presents the mean number of Fos-positive cells in other
areas of interest for all 4 experimental groups at P8. Three
patterns of results are seen: First, in addition to LC, DMH, and
SCN, there were 3 areas exhibiting significantly higher Fos-ir in
the Stimulated/Saline group compared with the three other
PLOS ONE | www.plosone.org

9

September 2012 | Volume 7 | Issue 9 | e45338

Development of SCN Activity and Arousal

Figure 8. Model of SCN-DMH-LC developing circuitry between P2 and P8. Neural projections among the SCN, vSPVZ, DMH, and LC at P2 are
sparse, whereas bidirectional projections among all areas develop by P8. The development of neural connectivity between the SCN and downstream
structures may be associated with decreased contributions of SCN-produced humoral factors on sleep-wake behavior.
doi:10.1371/journal.pone.0045338.g008

P,.0005) and LC (t6 = 8.5, P,.0001). At P2, cell bodies were
evident within the LC, whereas at P8 cell bodies and axon
terminals were detected in both the SCN and LC (Figure 3, insets),
thus indicating the development of bidirectional projections
linking each of these two structures with the DMH.
Beyond the SCN and LC, at P2 we observed cell bodies and
axon terminals within the vSPVZ and axon terminals within the
paratenial thalamus (PT) and VMH. At P8, we observed axon
terminals within the PT, VMH, DR, DTg, VTg, LH, VLPO, and
paraventricular nucleus (PVN).
Two pups received injections of CTB that missed the DMH
region. In one pup at P2, the injection was in an undefined region
dorsal to the DMH and ventral to the thalamic nucleus submedius,
resulting in no visible fluorescent labeling anywhere in the brain
other than the injection site. In a second DMH ‘‘miss’’ at P8, the
CTB injection site was within the medial tuberal nucleus, just
lateral and dorsal to the DMH; this resulted in fluorescent axon
terminals in the dorsal raphe nucleus, dorsal tegmental nucleus,
and motor trigeminal nucleus. Importantly, for both of these
misses, fluorescent labeling was very different from that seen with
injections that hit the DMH.

stimulations in last 5 min; t10 = 0.6, NS). Nonetheless, the total
number of stimulus presentations over the 30-min stimulation
period was not significantly different between saline-treated
(161.9614.8) and DSP-4-treated (149.3611.2) pups (t10 = 1.3,
NS). A repeated-measures ANOVA over the entire 30-min
stimulation period revealed a significant effect of time (F5,60
= 6.9, P,.0001) and a significant group x time interaction (F5,60
= 7.1, P,.0001), but not a significant effect of group (F1,10 = 3.9,
NS).

Bidirectional projections within the SCN-DMH-LC circuit
develop between P2 and P8
Given the evidence presented above of increasing functional
connectivity among the SCN, DMH, and LC between P2 and P8,
we next determined whether direct neural projections develop
among these 3 structures between P2 and P8.
DiI crystal placed unilaterally within the SCN revealed
a developmental increase in connectivity with the DMH (Figure 2).
This observation was supported by measurement of mean
fluorescent intensity, which was significantly higher at P8 than at
P2 in the DMH (t6 = 10.7, P,.0001) but not the LC (t6 = .55, NS).
At P8, both cell bodies and axon terminal were evident in the
DMH (Figure 2, inset), thus indicating that bidirectional projections develop between the SCN and DMH by this age. In contrast,
very little fluorescence within the LC was observed at either age.
Beyond the DMH and LC, at P2 we observed axon terminals
within the lateral septum (LS), MPOA, and vSPVZ. At P8, we
observed cell bodies within the vSPVZ and axon terminals within
the LH, ventromedial hypothalamus (VMH), vSPVZ, LS, MPOA,
and supraoptic nucleus (SON).
Unilateral injection of CTB into the DMH revealed a developmental increase in connectivity with the SCN and LC
(Figure 3). In support of these observations, fluorescent intensity
was significantly higher at P8 than at P2 in the SCN (t6 = 7.3,
PLOS ONE | www.plosone.org

SCN lesions at P1 eliminate day-night differences in sleep
and wakefulness
Although the SCN has limited direct or indirect connectivity
with the brainstem at P2, day-night differences in sleep and
wakefulness are detectible at that age [3]. To determine if the SCN
is critical for this early expression of day-night differences in sleep
and wakefulness, we performed SCN lesions at P1 and recorded
EMG activity in pups at P2.
Log-survivor distributions for pooled sleep and wake bout
durations for sham and SCN-lesioned pups are presented in
Figure 4A. Straight lines on these semi-log plots are indicative of
exponential distributions [4,36]. Based on Akaike weight analyses
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of pooled and individual data (see Methods), sleep and wake bout
for shams and SCN-lesioned pups distributed exponentially during
the day and night (Akaike weights equal to 1).
The insets in Figure 4A present mean sleep and wake bout
durations in sham and SCN-lesioned pups. For shams, and
consistent with previous findings [3], mean sleep and wake bout
durations were shorter at night than during the day. In contrast,
SCN-lesioned pups did not exhibit significant day-night differences
in mean sleep or wake bout durations. For wake bout durations,
ANOVA revealed a significant main effect of recording time
(F1,16 = 9.0, P,.01) and a significant group x recording time
interaction (F1,16 = 5.7, P,.05), but not a significant main effect of
group (F1,16 = 3.5, NS). For sleep bout durations, ANOVA
revealed a significant main effect of group (F1,16 = 6.3, P,.05)
and a group x recording time interaction (F1,16 = 6.8, P,.05), but
not a significant main effect of recording time (F1,16 = 3.6, NS). In
addition, post hoc tests revealed that during the day, mean sleep
and wake bout durations differed significantly between sham and
SCN-lesioned groups.
Figure 4B shows the extent of the lesions. The smallest (green
filled) and largest (yellow filled) lesions across all pups are
presented. Adjacent areas to the SCN were also affected by the
electrolytic lesions in some pups, including parts of the optic
chiasm and MPOA.
Six pups from 6 separate litters received electrolytic lesions that
missed the SCN and spared all cells within it. In these cases, lesions
were observed within the MPOA and PVN. Importantly, pups
with these ‘‘misses’’ exhibited day-night differences in sleep and
wakefulness that were similar to those of shams.
A total of 4 SCN-lesioned pups died before recording at P2
(mortality rate = 13.3%). Finally, no immediately obvious
behavioral differences were detected in lesioned pups as compared
to controls.

wake bout durations are presented as insets in Figure 5B. For sleep
bouts, ANOVA revealed significant main effects of group
(F1,20 = 16.3, P,.001), but no significant effects for recording
time (F1,20 = 2.9, NS) and not a significant group x recording time
interaction (F1,20 = 3.9, NS). For wake bouts, ANOVA revealed
a significant main effect for group (F1,20 = 14.9, P,.005), but no
significant effect of recording time (F1,20 = 0.06, NS) and no
significant group x recording time interaction (F1,20 = 2.5, NS).
Two P2 transected pups died before recording (mortality rate
= 7.7%) and 3 P8 pups died before recording (mortality rate
= 11.1%). No immediately obvious behavioral differences were
detected in transected pups as compared to shams.

DMH lesions at P8 prevent day-night differences in
wakefulness at P21
The precollicular transections described above suggest a loss of
SCN humoral control of sleep-wake behavior by P8. To explore
this possibility using a more precise method, we performed DMH
lesions at P8 and recorded EMG activity at P21, an age by which
nocturnal wakefulness and power-law wake bout distributions have
emerged [3,4]. Because the DMH is a major neural output of the
SCN, elimination of day-night differences would provide further
support for the notion that the SCN relies on direct neural
connectivity to modulate sleep and wakefulness after P8.
Figure 6A presents log-survivor distributions for pooled sleep
and wake bout durations for DMH-lesioned and sham pups.
Whereas sleep bout distributions were almost identical in lesioned
and sham pups, wake bout distributions in the lesioned pups, in
comparison with those of the shams, were highly and similarly
fragmented during the day and night. Also, as expected for shams
at P21 [3,4,36], Akaike weight analyses of pooled and individual
data showed that sleep bouts followed an exponential distribution
and wake bouts followed a power-law distribution. But for pups
with DMH lesions, all distributions followed an exponential
distribution. All individual and pooled Akaike weights were equal
to 1.
The insets in Figure 6A provide mean sleep and wake bout
durations in DMH-lesioned and sham pups. These data support
the conclusions based on the log-survivor data. For mean sleep
bout durations, ANOVA revealed no significant main effects for
group (F1,20 = 2.2, NS) or recording time (F1,20 = 0.002, NS), and
no significant group x recording time interaction (F1,20 = 3.1, NS).
In contrast, for mean wake bout durations, ANOVA revealed
a significant main effect of group (F1,20 = 14.5, P,.005) and
recording time (F1,20 = 10.3, P,.005), and a significant group x
recording time interaction (F1,20 = 12.1, P,.005). Post hoc tests
revealed a significant difference between mean wake bout
durations at night in DMH-lesioned pups as compared with
shams. Also, consistent with previous findings [3], percentage of
time awake at night was significantly increased in shams but not in
lesioned pups. ANOVA revealed no main effect of group (F1,20
= 3.2, NS), but did reveal a significant main effect of recording
time (F1,20 = 4.4, P,.05) and a significant group x recording time
interaction (F1,20 = 11.2, P,.005).
Figure 6B shows the extent of the chemical lesions in the DMH.
In addition to damage to the DMH, adjacent areas were also
affected in some pups, including parts of the anterior hypothalamus (AHP) and posterior hypothalamus (PH).
Six additional pups from 6 litters received lesions that spared all
cells within the DMH. In these cases, lesions were found in the
anterior hypothalamic area and posterior hypothalamus. These
‘‘misses’’ exhibited day-night differences in sleep and wakefulness
and power-law distributions of wakefulness that were similar to
controls.

Precollicular transections at P2 and P8 exert different
effects on day-night differences in sleep and wakefulness
Given that the SCN is functional at P2 but lacks connectivity
with downstream structures, it could be that its influence on sleep
and wakefulness is mediated humorally. To test this possibility, we
performed precolllicular transections at P2 and P8 to physically
isolate the SCN from the brainstem.
Figure 5 presents log-survivor distributions for pooled sleep and
wake bout durations for transected and sham P2 and P8 rats
recorded during the day or night. Based on Akaike weight analyses
of pooled and individual data, all sleep and wake data distributed
exponentially (Akaike weights equal to 1). The range of the
transections at each age is also shown. Note that all precollicular
transections were caudal to the SCN and DMH.
At P2 (Figure 5A), log-survivor distributions indicate continued
expression of day-night differences in sleep and wake bouts after
precollicular transection. Mean sleep and wake bout durations are
presented as insets in Figure 5A. For mean sleep bouts, ANOVA
revealed significant main effects of group (F1,20 = 13.6, P,.005)
and recording time (F1,20 = 22.4, P,.001), but not a significant
group x recording time interaction (F1,20 = 1.9, NS). For wake
bouts, ANOVA revealed a significant main effect of recording
time (F1,20 = 9.5, P,.01), but no significant main effect of group
(F1,20 = 2.9, NS) or group x recording time interaction (F1,20 = .04,
NS).
At P8 (Figure 5B), precollicular transections eliminated daynight differences in sleep bouts. However, consistent with previous
observations at P8 [3], wake bouts did not exhibit day-night
differences in sham subjects; thus, day-night differences in wake
bouts could not be eliminated by the transections. Mean sleep and
PLOS ONE | www.plosone.org
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precollicular transections at P8 eliminate the day-night differences
in sleep behavior normally observed at that age; and (vi) DMH
lesions at P8 eliminate the day-night differences in wake behavior
normally observed at P21. Finally, (vii) SCN lesions at P8
produced effects at P21 that were indistinguishable from those of
DMH lesions, as would be expected if the SCN and DMH work
closely together to modulate circadian sleep-wake behavior [37].
Using adult rats, Deboer et al. [8] showed that both active sleep
and wakefulness are associated with spontaneous increases in SCN
neural activity. In contrast, here we assessed whether arousing
stimulation can evoke changes in SCN activity. Because Todd et al.
[9] found, using P2 rats, that 30 min of arousing stimulation
increased Fos-ir in the LC and DMH but not the SCN, we
predicted that this same procedure would activate the SCN (in
addition to the LC and DMH) later in development. Using P8 rats,
this prediction was confirmed. In addition, destruction of LC
noradrenergic terminals with DSP-4 [12–14] prevented evoked
increases in SCN and DMH Fos-ir, thus indicating mediation by
the LC. It is important to emphasize that DSP-4 is selective in its
destruction of noradrenergic terminals arising from the LC [12];
destruction of these terminals likely leads to retrograde degeneration [38], resulting in the decreased Fos-ir in the LC
observed here.
Given that SCN activity in adults increases spontaneously
during both active sleep and wakefulness [8], it is interesting that
the LC is nearly silent during active sleep but highly active during
wakefulness in infant [39] and adult [40] rats. Accordingly, it may
be that increased SCN activity during active sleep is mediated by
an LC-independent pathway. In contrast, an LC-dependent
pathway may activate the SCN during wakefulness; this LCdependent pathway may be the same one that drives SCN activity
in response to arousing stimulation in infants.
Although Deboer and colleagues [8], using adult rats, showed
that spontaneous SCN activity increases during the transition from
NREM to wakefulness, several studies report decreases in SCN
activity during wake-related movements or after forced arousal
(e.g., sleep deprivation) [41,44,45] (but see [42,43] for differing
results). Methodological differences most likely account for these
differences. Regardless, the increase we observed in SCN Fos-ir at
P8 was reliable and robust.
Similar variability in SCN responses to stress have been
reported in adults [46,47]. We addressed the issue of stress here
by measuring Fos-ir in the PVN. Even during the stresshyporesponsive period, which spans from P4 to P14 in rats and
is characterized by a blunted adrenocortical response to stress,
Fos-ir in the PVN can increase in response to a mild stressor such
as saline injection [27]. However, as in our previous study using P2
rats [9] we found no evidence of PVN activation in either of the
stimulated groups, thus suggesting that stress does not account for
our results.
It is possible that it was the somatosensory aspect of the cold
stimulation, rather than its arousing properties, that drove Fos-ir
within the SCN at P8. Our results suggest otherwise. Specifically,
whereas both barrel cortex and SCN were activated by cold
stimulation to the snout, only SCN activity was blocked by DSP-4
(see Table 1). In light of the well-established role of the LC in
behavioral arousal in adult rats [48–52], we conclude that barrel
cortex responded to the somatosensory aspects of the cold stimulus
and that the SCN responded to its arousing aspects.
As illustrated in Figure 8, the stimulation transmitted via the LC
to the DMH and SCN appears to depend upon connections that
develop between P2 and P8. We found sparse projections between
the SCN and other downstream structures at P2. At P8, however,
we found bidirectional projections among all three areas. This

A total of 6 DMH-lesioned pups died before recording at P21
(mortality rate = 16.7%). Finally, no immediately obvious
behavioral differences were detected in lesioned pups as compared
to controls.

SCN lesions at P8 prevent day-night differences in
wakefulness at P21
Figure 7 presents the effects of SCN lesions at P8 on day-night
difference in sleep and wakefulness in pups recorded at P21. In all
substantive ways, SCN lesions produced effects similar to those of
the DMH lesions described above. Log-survivor distributions for
pooled sleep and wake bout durations for SCN-lesioned pups and
shams are presented in Figure 7A. Again, SCN lesions had little
effect on sleep bout durations but produced substantial fragmentation of wake bouts and eliminated their power-law distribution.
The insets in Figure 7A present mean sleep and wake bout
durations in SCN-lesioned pups and shams. For mean sleep bout
durations, ANOVA revealed a significant main effect of group
(F1,20 = 4.9, P,.05), but not a significant main effect of recording
time (F1,20 = 1.3, NS) or a significant group x recording time
interaction (F1,20 = 0.2, NS). In contrast, for mean wake bout
durations, ANOVA revealed a significant main effect of recoding
time (F1,20 = 4.8, P,.05), but not of group (F1,20 = 3.7, NS), and
also no significant group x recording time interaction (F1,20 = 2.3,
NS). Again, percentage of time awake at night was significantly
greater in sham but not lesioned pups. ANOVA revealed no main
effect of group (F1,20 = 0.1, NS) or recording time (F1,20 = 4.1, NS),
and no significant interaction (F1,20 = 1.5, NS).
Figure 7B shows the extent of the SCN lesions. The smallest
(green filled) and largest (yellow filled) for each section are shown.
Adjacent areas were also damaged by the lesions in some pups,
including parts of the optic chiasm and MPOA. Because the optic
chiasm was damaged in some subjects, it is likely that some of the
SCN-lesioned subjects were at least partially blind. However, we
are confident that these lesions did not result in free-running
rhythms because even bilateral enucleation at P3 (with recording
through P35) or P11 (with recording through P21) did not impair
the expression of day-night differences in sleep-wake cyclicity [3].
Four additional pups from 4 litters received electrolytic lesions
that spared all cells within the SCN. In these cases, lesions were
found in the MPOA and PVN. These ‘‘misses’’ exhibited daynight differences in sleep and wakefulness and power-law
distributions of wakefulness that were very similar to those of
shams.
A total of 8 SCN-lesioned pups died before recording at P21
(mortality rate = 22.2%). Finally, no immediately obvious
behavioral differences were detected in lesioned pups as compared
to controls.

Discussion
The present findings document how the SCN, DMH, and LC
contribute to the development of the circadian control of arousal
and the consolidation of wakefulness. We have shown that (i) SCN
responsiveness to evoked arousing stimulation develops between
P2 and P8 and is mediated by the LC; (ii) the emergence of LCmediated activation of the SCN occurs contemporaneously with
the development of bidirectional projections among the SCN,
DMH, and LC; (iii) the SCN of P2 rats is critical for the day-night
differences in sleep and wakefulness reported previously [3]; and
(iv) precollicular transections at P2 do not eliminate these daynight differences, suggesting that the SCN or related structures
(e.g., DMH) modulate sleep-wake behavior at this age via the
release of humoral factors. We have also shown that (v)
PLOS ONE | www.plosone.org
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finding is consistent with work in hamsters showing that increased
connectivity between the SCN and downstream structures first
develops at P1 and continues through the end of the first postnatal
week [53].

Wake bout consolidation and power-law distribution
We have shown previously that the highly fragmented bouts of
sleep and wakefulness at P2 follow an exponential distribution and
that, by P15, only wake bouts transition to a power-law
distribution [3,4]. This transition to a power-law wake distribution
appears to require a functioning LC because treatment of infant
rats with DSP-4 selectively prevents the expression of power-law
behavior without producing fragmented bouts [36]. In contrast, as
shown here, lesions of the DMH or SCN eliminated power-law
wake behavior and also produced highly fragmented wake bouts.
Sleep bouts were unaffected.
One possible interpretation of the above results is that
consolidated wake bouts are necessary but not sufficient for the
expression of power-law wake bout distributions. In other words,
the loss of power-law wake distributions in pups with SCN and
DMH lesions may have been a consequence of extreme
fragmentation. Thus, there may be two discriminable forms of
wake consolidation: One produced by a circuit that proceeds from
the SCN to the DMH and into the brainstem–bypassing the LC–
to produce consolidated wake bouts that follow an exponential
distribution, and the other produced by a circuit that includes the
LC and contributes to the expression of power-law wake bout
distributions.
Surprisingly, of the many SCN lesion studies in mammals [67–
69], only one has examined effects on sleep and wake bout
durations. Using adult squirrel monkeys, Edgar et al. [70] showed
that SCN lesions produced fragmented wake bouts without
affecting sleep bouts. Similarly, in the present study, SCN lesions
performed at P8, with recording at P21, produced fragmented
wake bouts without affecting sleep bouts. These findings suggest
that sleep bout consolidation is controlled by a separate forebrain
circuit, perhaps including the ventrolateral preoptic nucleus and
basal forebrain [31,71–73]. However, it remains possible that the
SCN contributes to sleep bout consolidation in rats at later ages
when day-night differences in sleep are observed [3,74].

Humoral factors
Despite sparse connectivity among the SCN, DMH, and LC at
P2, infant rats exhibit day-night differences in sleep and wake bout
durations [3]. To determine whether these effects depend upon the
SCN, we lesioned the SCN at P1 and recorded pups for sleep and
wakefulness during the day or night at P2. In contrast with shams,
pups with SCN lesions no longer expressed day-night differences
in sleep and wakefulness. Moreover, day-night differences in sleep
and wakefulness were retained in P2 rats with precollicular
transections that isolate the SCN from the brainstem. Therefore,
the expression of circadian rhythmicity at P2 is attributable to the
presence of a functioning SCN, perhaps exerting its behavioral
effects via humoral factors at this age (see Figure 8).
Humoral factors released by the SCN modulate behavioral and
physiological rhythms [54]. Several humoral factors have been
identified in infants and adults, including transforming growth
factor alpha (TGF-alpha) and prokineticin 2 (PK2) [55–61]. Both
TGF-alpha and PK2 affect locomotor activity rhythms in adult
mammals [56,62] and, although not tested here, may be involved
in modulating day-night differences in sleep and wakefulness at P2.
To our knowledge, the present findings are the first to provide
evidence, although indirect, of humoral modulation of sleep-wake
rhythms in the early postnatal period.
Our findings also suggest that any humoral modulation of sleepwake behavior that exists at P2 declines in efficacy over the first
postnatal week. Specifically, we saw no evidence of humoral
modulation of behavior in P8 rats with precollicular transections
(that isolate the SCN and DMH from the brainstem) or P21 rats
with DMH or SCN lesions. All together, these results strongly
suggest a diminishing role for humoral factors in the modulation of
sleep-wake behavior beyond the first postnatal week.
There are at least two hypotheses that could explain how
humoral factors might lose their efficacy across early development.
First, the developing direct neural connectivity described here may
induce organizational changes in the SCN such that, by P8, the
release of particular humoral factors is diminished. The fact that
encapsulated SCN grafts can function humorally for months after
implantation in the host [63] is not inconsistent with this
hypothesis as encapsulation would prevent innvervation-related
inductive interactions that could modify SCN function. Second,
the development of neural connections in this system may mask
any humoral influences on behavior that could remain in older
animals.
With regard to the first hypothesis, it is interesting that, to our
knowledge, only fetal and P1 SCN tissue has been effective in
restoring behavioral circadian rhythms in SCN-lesioned adult
hamsters [64,65]. Moreover, the age of the donor influences the
ability of SCN grafts to restore circadian rhythmicity in hamsters
[65]: Whereas unencapsulated SCN grafts from embryonic or P1
subjects are equally effective in restoring circadian locomotor
rhythms, grafts from older donors (P5-P10) are ineffective. On the
other hand, the SCNs of P10–14 mice release paracrine signals in
vitro that are sufficient to restore cellular synchrony and amplitude
of pacemaking in SCN circuits lacking vasoactive intestinal peptide
(VIP) [66]. Clearly, more work is needed to determine if there is an
age-related decline in the SCN’s capacity to release humoral
factors and, if so, the mechanisms that mediate that decline.

PLOS ONE | www.plosone.org

Conclusions
All together, the present results elucidate the neural mechanisms
underlying the consolidation and circadian regulation of arousal in
developing animals. Our results suggest a transition in the SCN’s
modulation of arousal–from humoral to non-humoral–corresponding with emerging bidirectional connectivity with downstream structures by P8. By P21, the SCN, DMH, and LC work
together to make possible the extended periods of wakefulness
necessary for the emerging independence that is a defining feature
of weaning [75].
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